Latest filing published 13 Mar 2024 for Nykode Therapeutics ASA, €12k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Harald Gurvin: trading record in brief
Harald Gurvin appears in our data through filings on Nykode Therapeutics ASA shares, published by Oslo Børs. We count 3 filings; the first trade dates from 4 May 2021 and the latest from 13 March 2024.
Every open-market trade on record is a purchase: 2 purchases worth €41k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 option exercise. So far in 2024, the count stands at 2 purchases and no sales.
On 13 March 2024 came the latest disclosure, an open-market purchase for €12k in Nykode Therapeutics ASA. This summary is built from Oslo Børs disclosures alone and does not predict where the share price will go.
Companies and markets linked to Harald Gurvin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ NOK 14.0029.5% of flowShareXOSLOSLO:613304Canonical exit: 11 Jun 2024 (T+90)
- 20,000 shares@ NOK 16.5970.5% of flowShareXOSLOSLO:612556Canonical exit: 2 Jun 2024 (T+90)
- @ €7.6706OptionMERKOSLO:532149
3 of 3 declarations